Acrobiosystems for English
icon_bulk_orderAnfrage Sammelbestellung/Schnellbestellung
user
  1. Übersicht
  2. Mein Profil
  3. Meine Adresse
  4. Meine Bestellungen
  5. Acro-Mitgliedschaft
Login Registrieren
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
Es befinden sich keine Waren im Warenkorb !
Mein Warenkorb|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > PAR2

PAR2

Brief Information

Name:Protease-activated receptor-2
Target Synonym:Receptor, PAR-2,F2RL1,Thrombin receptor-like 1,G-protein coupled receptor 11,F2R Like Trypsin Receptor 1,PAR2,GPR11,Protease-Activated Receptor 2,Coagulation Factor II (Thrombin) Receptor-Like 1,Proteinase-Activated Receptor-2,Proteinase-activated receptor 2,Coagulation factor II receptor-like 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Product> Filter Results
Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
PA2-H52P7 Human Human PAR2 Full Length Protein (VLP)
ACRO Quality

Part of Bioactivity data

PA2-H52P7-ELISA
PAR2 ELISA

Immobilized Human PAR2 Full Length Protein (VLP) (Cat. No. PA2-H52P7) at 5 μg/mL (100 μL/well) can bind Anti-PAR2 Antibody, Human IgG1 with a linear range of 1-39 ng/mL (QC tested).

Protocol

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
TEV-56192 TEV-56192 Phase 1 Clinical Teva Pharmaceutical Industries Ltd Nervous System Diseases Details
OA-235i OA-235i Phase 1 Clinical Oasis Pharmaceuticals LLC Metabolic Dysfunction-Associated Steatotic Liver Disease Details
MEDI-0618 MEDI-0618 Phase 1 Clinical Astrazeneca Plc Chronic Pain Details
TEV-56192 TEV-56192 Phase 1 Clinical Teva Pharmaceutical Industries Ltd Nervous System Diseases Details
OA-235i OA-235i Phase 1 Clinical Oasis Pharmaceuticals LLC Metabolic Dysfunction-Associated Steatotic Liver Disease Details
MEDI-0618 MEDI-0618 Phase 1 Clinical Astrazeneca Plc Chronic Pain Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Nachricht schicken

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap